Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. RVMD
RVMD logo

RVMD

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

RVMD News

Revolution Medicines Releases Updated Clinical Data for Zoldonrasib

22h agoNewsfilter

Revolution Medicines Closes Upsized Offering of 12.1 Million Shares

2d agoNewsfilter

Revolution Medicines Raises Approximately $1.5 Billion in Public Offering

5d agoseekingalpha

Revolution Medicines Prices $2 Billion Upsized Public Offerings

5d agoNASDAQ.COM

Revolution Medicines Prices Concurrent Public Offerings Raising $1.5 Billion

5d agoNewsfilter

Revolution Medicines Raises $1.5 Billion in Public Offerings

5d agoYahoo Finance

Revolution's Cancer Drug Trial Shows Significant Survival Improvements

5d agostocktwits

Revolution Medicines Plans $1 Billion Financing

6d agoNASDAQ.COM

Revolution Medicines Hits All-Time High on Trial Success

6d agoYahoo Finance

U.S. Stocks Close Higher, Led by Tech Sector Gains

6d agoNASDAQ.COM

Mixed US Stock Performance Amid Soaring Oil Prices

6d agoNASDAQ.COM

Oil Price Surge Triggers Market Volatility

6d agoNASDAQ.COM

Revolution Medicines Plans to Raise $1 Billion Through Public Offerings

6d agoseekingalpha

Revolution's Cancer Drug Shows Promising Results in Trials

6d agostocktwits

Stock Price Movements of Various Companies

6d agoCNBC

Revolution Medicines Reports Positive Phase 3 Data for Daraxonrasib

Apr 13 2026seekingalpha